2000
DOI: 10.1081/clt-100100949
|View full text |Cite
|
Sign up to set email alerts
|

Hepatic Damage Caused by Chronic Arsenic Toxicity in Experimental Animals

Abstract: We have demonstrated hepatic fibrosis due to long-term arsenic toxicity in an animal model. Initial biochemical evidence of hepatic membrane damage, probably due to reduction of glutathione and antioxidant enzymes, may be seen by 6 months. Continued arsenic feeding resulted in fatty liver with serum aminotransferase and alanine aminotransferase elevated at 12 months and hepatic fibrosis at 15 months. The murine model is proposed as relevant to epidemic human toxicity in areas of arsenic contamination.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

15
101
1
3

Year Published

2002
2002
2019
2019

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 160 publications
(123 citation statements)
references
References 35 publications
15
101
1
3
Order By: Relevance
“…The results revealed the aberrant expression of genes encoding oxidative stress, DNA damage and repair, and cell proliferation (26). These findings are consistent with those observed in livers of animals chronically fed arsenic-containing water for 48 weeks and longer (27,28), and in livers of mice receiving repeated arsenic injections (28,29). These lesions and aberrant gene expressions could potentially progress to neoplastic changes as seen in chronic arsenic-transformed rat liver cells (30) as well as in mice given repeated arsenic injections where hepatic proliferative and pre-neoplastic lesions have recently been observed (29).…”
Section: Clinical Symptoms Of Patientssupporting
confidence: 80%
“…The results revealed the aberrant expression of genes encoding oxidative stress, DNA damage and repair, and cell proliferation (26). These findings are consistent with those observed in livers of animals chronically fed arsenic-containing water for 48 weeks and longer (27,28), and in livers of mice receiving repeated arsenic injections (28,29). These lesions and aberrant gene expressions could potentially progress to neoplastic changes as seen in chronic arsenic-transformed rat liver cells (30) as well as in mice given repeated arsenic injections where hepatic proliferative and pre-neoplastic lesions have recently been observed (29).…”
Section: Clinical Symptoms Of Patientssupporting
confidence: 80%
“…31,32 Therefore, we asked whether trolox could affect As 2 O 3 -associated hepatocellular damage in vivo. Mice were randomly divided into groups of five mice and treated with two doses of trolox and a dose of As 2 O 3 (7.5 mg/kg) reported to be moderately toxic.…”
Section: Trolox Significantly Enhances As 2 O 3 -Induced Apoptosis Ofmentioning
confidence: 99%
“…Thus an agent able to reduce the toxic potential of arsenic in liver cell would clearly be a use full compound for arsenical chemotherapy. The liver has long been identified as a target organ of arsenic exposure [27], its importance as an organ arsenic biotransformation is well established [28]. The mechanism by which arsenic directly damages the liver including oxidative stress [29,30], enhanced inflammation and alteration in cellular methylation status has been investigated [31].…”
Section: Discussionmentioning
confidence: 99%